Breast cancer exhibits complex and heterogeneous characters with three typical clinical subtypes, such as hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) positive, and triple-negative breast cancer (TNBC). Here, ERBB2 is linked to breast cancer.